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This article presents the hypothesis that acupuncture enhances anticancer immune functions by stimulating natural killer (NK)
cells. It provides background information on acupuncture, summarizes the current scientiﬁc understanding of the mechanisms
through which NK cells act to eliminate cancer cells, and reviews evidence that acupuncture is associated with increases in NK cell
quantity and function in both animals and humans. The key contribution of this article involves the use of cellular immunology
and molecular biological theory to interpret and synthesize evidence from disparate animal and human studies in formulating
the ‘acupuncture immuno-enhancement hypothesis’: clinicians may use acupuncture to promote the induction and secretion of
NK-cell activating cytokines that engage speciﬁc NK cell receptors that endogenously enhance anticancer immune function.
1.Introduction
Compelling research ﬁndings demonstrate that acupuncture
reduces the incidence of chemotherapy-induced acute vom-
iting [1]. Suggestive ﬁndings show that clinicians could use
acupuncture to potentially manage cancer-related pain of
articular and soft tissue origin [2–7]. Promising evidence
suggests that acupuncture relieves fatigue in cancer patients
and survivors [5, 6, 8, 9]. Preliminary results are accumu-
latingthatacupuncturealleviatescancer-relatedneurological
issues, breathlessness, hot ﬂashes and xerostomia [5–7]. In
sum, there are substantial empirical grounds to assume that
clinicians could use acupuncture to help patients better
tolerateconventionalcancertherapiesbyreducingassociated
side-eﬀects [1–8]. Further, the evidence is very strong that
acupuncture is an extremely safe therapy [10]. In short, the
research implies that acupuncture is a helpful, versatile and
safe treatment modality for patients with cancer.
Despite potential beneﬁts, however, the conventional
oncology community has shown itself reluctant to inte-
grate acupuncture and other complementary and alternative
medicine (CAM) modalities into their treatment plans for
patients with cancer [11]. One concern is that symptoms
treated with CAM modalities are often transitory, which
opens the possibility that symptomatic relief may be due to
spontaneous remission rather than resulting from a CAM
intervention [12–14]. A second concern is that the current
procedures of disclosure may undermine informed consent
and thereby compromise patient autonomy in such a way
that produces negative consequences for conventional ther-
apeutic procedures [15]. A third and related concern is that
the scientiﬁc community lacks both the scientiﬁc evidence
and biomedical understanding to reasonably suppose that
CAM procedures may increase either survival or disease-free
survival of patients with cancer [12–14].
We address these concerns by harnessing theory from
cellular immunology and molecular biology to interpretive
and synthesize disparate empirical studies into a hypothesis
about speciﬁc mechanisms through which acupuncture
enhances anticancer immune function with implications
for prevention and management of the cancer. Speciﬁcally,
we hypothesize that clinicians may use acupuncture to
increase the cytotoxic activity of natural killer (NK) cells by
promoting cross-talk between the neurotransmitter network
and immune system that is [1] orchestrated by nitric oxide,
β-endorphins and cytokines and [2] anchored by opioid2 Evidence-Based Complementary and Alternative Medicine
and NK cell receptors. We refer to this as the “acupuncture
immuno-enhancement hypothesis”. For reasons we describe
below, we think that one acupuncture point is pivotal
although we also expect that treatment protocols involving
synergistic points will produce better results. But this detail
should not distract the reader from our overall theme:
acupuncture can be employed to improve the function and
level of NK cells. Our main theme is of great importance to
patients with cancer (and the conventional providers who
treat them) because NK cells are immune cells known to
play a key role in directly killing cancer cells and regulating
anticancer immune functions [16–18].
To develop the hypothesis that acupuncture enhances
endogenous anticancer immune functions with implications
for molecular-level carcinogenic control, we begin with a
primer on acupuncture and a review of studies that have
investigated the impact of acupuncture stimulation on NK
cell function in animals and humans. We then provide
an overview of the advancing molecular biological under-
standing of NK cells. Our key contribution follows in the
subsequent section, where we harness cellular immunology
and molecular biological theories to interpret and integrate
disparate research ﬁndings in formulating a hypothesis.
Speciﬁcally, we hypothesize that acupuncture stimulation
enhances NK cell stimulating cytokines and NK cell anti-
cancer cytotoxic activity and proliferation through speciﬁc
cellular and molecular mechanisms, thus enhancing host
resistance to cancer in both rodents and humans. As a ﬁnale,
we assess the evidential basis of our hypothesis and point to
fresh research frontiers.
2.Acupuncture:
Three ClinicallyImportantAcupoints
Acupuncture encompasses a heterogeneous set of needling
methods by which practitioners induce biologic responses
that activate pathways in the peripheral and central nervous
systems[19].Conventionally,acupunctureinvolvesinsertion
of a very thin needle into acupoints and is sometimes
accompanied by thrusting and/or twirling. One speciﬁc
type of acupuncture involves transmitting weak pulses of
electrical current through acupuncture needles inserted into
acupuncture points. In some instances, the distinction is
clinically relevant. For example in the case of chemotherapy-
induced acute vomiting [1], the evidence indicates that
acupuncture administered with electricity (electroacupunc-
ture) is eﬀective although acupuncture without electricity
(manual acupuncture) is not. Acupoints are in the vicinity
of peripheral nerves and their bifurcations, neuromuscu-
lar attachments, blood vessels and ligaments [20]. The
World Health Organization identiﬁes 361 precisely-speciﬁed
anatomically distinct sites known as acupoints [21].
ThreeofthemostcommonlyusedacupointsareStomach
36 (ST36, in Chinese Zusanli), Pericardium 6 (PC6, in
Chinese Neiguan) and Large Intestine 4 (LI4, in Chinese
Hegu). PC6, known as the “antinausea acupoint”, is located
between the tendons of palmaris longus and ﬂexor carpii
radialis at 2 body-inches (a body-inch or a cun is the
greatest width of a patient’s thumb at the distal phalanx)
above the wrist crease [22]. Stimulation of PC6 is found to
be beneﬁcially associated with the prevention and relief of
nausea and/or vomiting in three separate reviews published
by the Cochrane collaboration, a highly prestigious interna-
tional initiative that involves the application of a rigorous
process to systematically review the eﬀects of biomedical
interventions in randomized controlled trials across all areas
of health care [23, 24] .T h er e v i e w sa r eb a s e do ne v i d e n c e
from clinical trials, many of which are focused speciﬁcally
on PC6, that involve thousands of patients who experienced
relief of nausea and/or vomiting associated with surgery
[25], chemotherapy [1]o rp r e g n a n c y[ 26]. Furthermore,
a recently published randomized controlled trial found
acupuncture as eﬀective as commonly used antiemetic drugs
in relieving nausea [27].
LI4 is the most commonly used analgesic acupoint,
especiallyforneckandheadpain;itisknownasthe“antipain
acupoint” [28]. LI4 is located at the highest point on the
adductor pollicis muscle between the thumb and the index
ﬁnger. Authors of a 2009 Cochrane review analyze 11 trials
with 2317 patients to conclude that the evidence indicates
that acupuncture would be a valuable non-pharmacological
tool in patients with frequent episodic or chronic tension-
type headaches [29]. In a separate 2009 Cochrane review,
authors review 22 trials with 4419 patients, to conclude
that available studies indicate that acupuncture is at least
as eﬀective as, or possibly more eﬀective than, prophylactic
drug treatment, and has fewer adverse eﬀects and that
therefore acupuncture should be considered as a treatment
option [30]. Pragmatic (practice-oriented) research shows
acupuncture to be a cost-eﬀective treatment for headaches
[31].
In acupuncture clinics, providers most commonly needle
ST36 to enhance immune functioning [32]. For this reason,
we term ST36 as the “immuno-enhancing acupoint”. ST36
is located 5 cm below the patella and 2 cm lateral of the
anterior crest of the tibialis anterior muscle [33, 34]. This
review makes the case that one way in which acupuncture
enhancesimmunefunctionisthroughthemodulationofNK
cells.
3. SuggestiveEvidencethat
AcupunctureStimulatesNKCells
Limited published studies provide suggestive evidence that
acupuncture induces an increase of NK cell activity both in
animals and humans. In rats, researchers have shown that
carrying out acupuncture on the ST36 acupoint (0.5–1h a
day for 2-3 days) induces, in the spleen, signiﬁcant increases
of NK cell tumoricidal activity and secretion of interleukin-2
(IL-2) and interferon-γ (IFN-γ)[ 35]; and parallel increases
in expression of the NK cell receptor CD94, protein tyrosine
kinase (PTK) and adhesion molecule VCAM-1 genes, and
decreases of protein tyrosine phosphatase (PTP) and SHP-
1 genes that are critically involved in regulation of NK cell
activity [36]. Importantly, researchers have demonstrated
that acupuncture stimulation of the ST36 acupoint increases
the suppressed NK cell activity in surgically traumatized rats
[37].Evidence-Based Complementary and Alternative Medicine 3
Table 1: Changes of CD16+ and CD56+ NK cells in peripheral
blood following acupuncture.
Timing of measurement CD16+ (%) CD56+ (%)
Before acupuncture 0.8 ± 0.2 5.8 ± 0.7
First day after acupuncture 1.6 ± 0.3∗ 7.5 ± 1.0∗
Second day after acupuncture 2.2 ± 0.5∗ 8.5 ± 1.5∗
Eighth day after acupuncture 2.1 ± 0.4∗ 11.2 ± 1.8∗∗
Data are means ± SD. Blood samples were drawn from the forearm vein
with a syringe containing heparin in 17 healthy volunteers aged 21–
51 years who received one acupuncture treatment on August 10, 2005.
The mononuclear blood cells were separated, stained with ﬂuorescent
conjugatedmonoclonalantibodiesandanalyzedwithﬂuorescence-activated
cell sorter. Table adopted from Yamaguchi et al. [39].
∗P<. 05, ∗∗P<. 01: statistical signiﬁcance of diﬀerences of the results
compared with baseline levels.
In humans, Arranz and colleagues in Spain carried out a
clinical trial comparing peripheral blood NK cell cytotoxic
activity in 36 female patients suﬀering from high levels of
anxiety before and after acupuncture to 20 healthy controls
[38]. At baseline, women with anxiety had NK cell activity 3-
foldlowerthanhealthycontrols(P<. 0001).Afractionofthe
patients were then administered one manual acupuncture
treatment with needles retained in place for 30min at ST36
and several other points (SI3, HT3, HT5, LI11, PC6, LI4,
TH5, CV3, CV4, CV6, CV15, GB34, GB43, SP6, LV2, UB60,
KD6, GV20). Immediately and also at 72h following the
treatment, NK cell activity in the anxious women was still
signiﬁcantly lower than that of the healthy controls (P<. 01,
P<. 05), but it progressively and signiﬁcantly increased
relative to the patient’s baseline levels (P<. 05, P<. 0001),
respectively. Remarkably, 1 month after ﬁnishing a series
of 10 acupuncture treatments, the anxious women showed
a complete restoration of NK cell cytotoxic activity, which
became the same as that in the healthy controls.
Yamaguchi and colleagues in Japan carried out a clinical
trial with 17 healthy volunteers from whom they drew
blood from a forearm vein 1h before and 1, 2 and 8 days
after treatment [39]. Acupuncture treatment was manual
and consisted of insertion of a needle for 5s into ST36
and a few other points, such as BL18, BL20 and BL23.
The scientists found that patients exhibited progressive
and statistically signiﬁcant increases in the percentage of
circulating NK cells subsequent to acupuncture treatment at
days 1–8 (compared to baseline). Increased NK cell levels
were evidenced by counts of both low aﬃnity Fcγ receptor
(CD16) and neural cell adhesion molecule (NCAM, CD56)
positive peripheral blood mononuclear cells (Table 1). In
the same study, authors found a respective 7- and 9-fold
increases in the number of IFN-γ producing peripheral
blood cells subsequent to treatment at days 1 and 8 relative
to pretreatment. As NK cells are the major immune cells that
rapidly produce IFN-γ in response to “danger signals” and
IFN-γ is an important activator of the immune mechanisms
that eliminate cancer cells; we speciﬁcally reference this
ﬁnding below in the course of formally developing our
hypothesis.
Petti and colleagues in Italy carried out a clinical trial
on 120 patients with pain syndromes [40]. Of the 120
patients, 30 were selected as controls. The remaining 90
patients were randomized into three diﬀerent treatment
groups, one of which assessed NK cell activity. All patients
in the treatment groups received acupuncture stimulation of
ST36 (in conjunction with the LI4 acupoint) with needles
retained in place for 30 min. Peripheral blood of the 30
untreated patients and 30 treated patients per each group
was examined for the presence of β-endorphin and number
of NK cells. While untreated patients were examined once,
treated patients were examined before, and 30 min and
24h after acupuncture treatment. The scientists found an
increase in β-endorphin after 30min of treatment in the
peripheralbloodofpatientswhoreceivedacupuncture.More
importantly, 30min and 24h after acupuncture treatment,
they found that the peripheral blood of 40% and 50% of
patients, who had low numbers of peripheral blood NK
cells before treatment, had increased numbers of NK cells,
respectively.
Together, these reviewed studies provide intriguing evi-
dence that acupuncture stimulation modulates NK cell
number and function, with the animal studies indicating
the immuno-enhancing acupoint (ST36) to be pivotal. For
the sake of clarity, we emphasize that we are not claiming
this reviewed evidence is conclusive; rather our claim is
that there is a suﬃciently strong evidential base to warrant
theoretical exploration, from a cellular immunology and
molecular biological perspective, of possible mechanisms by
whichacupuncturemodulatesNKcellnumberandfunction.
The next section lays the groundwork for such a task by
providing an overview of the current understanding of NK
cells.
4.NKC ellsA r eI mpo rtantEff ect o rso f
Anticancer Immune Mechanisms
NK cells are essential eﬀector cells of the innate immune
system that spontaneously kill transformed and infected
cells, and therefore represent the ﬁrst line of the host
immune defense against cancer and pathogens [41–43]. NK
cells utilize two major constitutive mechanisms to recognize
and kill cancer cells: the secretory/necrotic mechanism,
which is mediated by cytolytic activity of the secreted
cytotoxic molecules perforin and granzymes and non-
secretory/apoptotic mechanism, which is mediated by trans-
membrane TNF superfamily ligands (Figure 1)[ 44, 45].
The secretory/necrotic mechanism is operative against rare
leukemiatargetcells(e.g.,inhumans,K562erythroleukemia;
in mice, Yac-1 T-cell leukemia) that both express ligands
for killer cell activating receptors (KARs) and lack MHC
class I molecules. This killing mechanism is induced in NK
cells by balanced triggering of KARs (i.e., NKp30, NKp44,
NKp46 and NKG2D) with KAR ligands (e.g., the MHC class
I homologues MICA and MICB) and disengaging killer cell
inhibitory receptors (KIRs) in the absence of MHC class
Im o l e c u l e s[ 46–48]. The non-secretory/apoptotic killing
mechanism is operative against all types of cancer cells and4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: NK cells in tumor surveillance. Reproduced with permission from Takeda and Okumura; Evid Based Complement Alternat Med.
2004:1:17–27.
is more eﬃcient than the secretory/necrotic mechanism. It
is triggered by a simultaneous engagement of the NK cell
transmembrane TNF superfamily ligands TNF, FasL and LT-
α1β2 with the corresponding cancer cell transmembrane
TNF family receptors TNFR1-TNFR2, Fas and LT-βR[ 42,
44, 45, 49]. These two NK cell cytotoxic mechanisms are
operative in both rodents and humans. Because normal
cells, as opposed to cancer cells, express relatively high
levels of MHC class I molecules and low levels of KAR
ligands [50, 51], and do not express the major proapoptotic
TNF family receptors TNFR1, TRAILR1 and TRAILR2 [52],
these two cytotoxic mechanisms mediate selective killing
of tumor cells without harming normal cells. Using these
constitutive and cancer-speciﬁc cytotoxic mechanisms, NK
cells spontaneously and rapidly eliminate newly formed
cancer cells and blood born metastases in vivo,a n dp r e v e n t
development of both primary tumors and metastases [41,
42]. To sum up, NK cells play an all-star role in protecting
hosts from carcinogenesis and metastases.
In addition to KIRs and KARs, NK cells express a
variety of other biologically important receptors, including
the receptors for Fc portions of immunoglobulin G (FcγRIII
and FcγRII) and inﬂammatory and immunoregulatory
cytokines [41, 53]. Therefore, NK cells respond not only
to transformed and infected cells but also to immune
complexes, inﬂammation and immune reactions by the
increases of their constitutive tumoricidal activities and
development of proliferation and production of immuno-
regulatory cytokines (e.g., IFN-γ, TNF and GM-CSF) and
chemochines (e.g., IL-8, MIP-1α,M I P - 1 β and RANTES)
[41, 42, 54–58]. The newly acquired functions may lead to
the remarkable augmentation of NK cell anticancer activities
and highly increased direct elimination of cancer cells [42],
andinductionandregulationofcancer-speciﬁcTh1adaptive
immune responses [59], which in concert can destroy and
controlgrowthofestablishedtumorsandmetastases.Among
the cytokines, IL-2 and IFN-α are particularly potent stimu-
lators of NK cells. These two cytokines produce remarkably
highgrowthandtumoricidalactivityinNKcells.Inresponse
to stimulation by IL-2 and IFN-α, NK cells become capable
of destroying all types of cancer cells in a highly eﬃcient
way,therebyleadingtoeliminationofestablishedtumorsand
metastases both in rodents and humans [60, 61]. Because of
their stimulating ability, IL-2 and IFN-α have been approved
by the FDA and used with a signiﬁcant therapeutic eﬃcacy
to treat patients with advanced malignant melanoma and/or
renal cell carcinoma.
NK cells arise from multipotent hematopoietic stem
cells (HSCs) that diﬀerentiate through a series of deﬁned
phenotypic stages. Precursor and immature NK cells were
identiﬁed in the bone marrow [62]. Cells with an imma-
ture NK cell phenotype were also found in murine liver
prompting the suggestion that some peripheral tissues could
a c ta sr e s e r v o i r sf o rl e s sd i ﬀerentiated NK cell progenitors
[63]. In humans, a precursor speciﬁed to the NK cell
lineage was identiﬁed in the lymph node [64]. Like other
hematopoietic and immune cells, human NK cells can be
fullyreconstitutedinmyeloablatedindividualsbyautologousEvidence-Based Complementary and Alternative Medicine 5
or allogeneic bone marrow HSCs [65–67]. Mature NK
cells can be generated in vitro from adult blood and bone
marrow cells containing HSCs. Both HSCs and mature NK
cells have been found in signiﬁcant numbers in multiple
rodent and human tissues/organs including bone marrow,
thymus, blood, spleen, lymph nodes, omentum, intestines,
skin, lung and liver. This indicates that NK cells are present
and can develop in multiple sites [65–67]. The interaction
between membrane-bound ligand LTα1β2 expressed on
HSCs and LTβR, expressed on stromal cells, as well as
stem cell factor (SCF, c-kit ligand), Flt3-L, IL-7 and IL-
15, secreted by stromal cells, provide critical signals that
induce diﬀerentiation cascades of NK cell development from
HSCs [65–67]. The number and function of host NK cells is
maintained at required levels by a well deﬁned homeostatic
mechanism that is mediated by soluble IL-7 and IL-15Rα-
transpresented IL-15 [68].
There are indications that the CNS may regulate anti-
cancer activities of NK cells via neuropeptides. In this regard,
endorphins are the most prominent among neuropeptides.
Endorphins are endogenous opioid neuropeptides that are
produced by the pituitary gland and hypothalamus during
strenuous exercise, high psychological excitement, pain,
orgasm and death [69, 70]. β-endorphin is a cleavage
product of pro-opiomelanocortin (POMC), which is also
the precursor of adrenocoticotrophic hormone (ACTH). It
is produced and released into the blood stream by pituitary
gland and into spinal cord and brain tissues by hypothalamic
neurons. NK cells sense and respond to endogenous and
exogenous opioids [71–74]. β-endorphin enhances both the
number and activity of NK cells in the spleens of mice
[71]. The eﬀect appears to be mediated via classical opioid
receptors, since augmentation of NK cell activity can be
inhibited by the antagonist naloxone [71]. β-endorphin has
also the ability to induce, in mice, increases in the expression
of cell adhesion molecules on NK cells and the number
of their conjugates with tumor cell targets, as well as the
expression of essential cytotoxic molecule of NK cell secre-
tory/necrotic cytotoxicity pathway (granzyme B) [72]. These
β-endorphin-induced molecular changes might be one of
the important mechanisms enhancing NK cell tumoricidal
activity [72]. Recent studies show that transplantation into
the paraventricular nucleus of hypothalamus of in vitro
diﬀerentiated embryonic hypothalamic neurons producing
increased quantities of β-endorphin results in signiﬁcant
increases in NK cell tumoricidal activity and NK-cell related
resistance to N-methyl-N-nitrosourea induction of prostate
cancers in rats [74]. In humans, β-endorphin has also been
shown to induceincrease in NK cell cytotoxic activity [73].
In contrast to the above described stimulatory signals
that activate and/or expand NK cells and increase their
anticancer activity, there is evidence indicating that the CNS
and cancer products have the ability to suppress NK cell
anticancer functions. For example, strong chronic emotional
or physical stress may induce highly increased and/or
prolongedsecretionofcorticosteroidsandendorphinswhich
suppress NK cell anticancer functions [75]. Further, high-
dose morphine consumption, as well as some cancer prod-
ucts, such as TGF-β, FasL, oncoproteins [71, 76, 77]a n d
soluble MIC ligands [78], provide strong inhibitory signals
for NK cells that counteract NK cell anticancer functions.
In brief, there is compelling evidence that: cytokines,
cancer products and CNS neuropeptides regulate NK cell
function, that NK cells regulate both innate and adaptive
anticancer immune functions, and that NK cells directly kill
cancer cells.
5.MolecularMechanisms ofAction
There is a coherent body of research indicating acupuncture
initiates a cascade of reactions that stimulates the produc-
tion and blood-borne dissemination of β-endorphins; the
research is largely but not exclusively focused on ST36.
Figure 2 traces out the mechanisms by which acupuncture
stimulation of ST36 activates the neurotransmitter network
in the brain. At the cellular level, needling ST36 induces the
enzyme nitric oxide synthase in keratinocytes [79, 80]. In
response,theseskincellsproducetheneurotransmitternitric
oxide [79]whichsendssignalsviathespinalcordtothebrain
[34, 81, 82]. Simultaneously, NO can also directly stimulate
NK cells and induce increases in NK cell tumoricidal activity
and proliferation [83]. In the brain, acupuncture stimulation
of ST36 elicits widespread and synchronized signals in the
cerebro-cerebellar circuit; this is especially marked in the
limbic system, which plays a central role in the regulation
of immunological functions [33]. Acupuncture-induced
signals stimulate the hypothalamus-pituitary-adrenal (HPA)
axis to release an endogenous opioid neurotransmitter (β-
endorphin), which travels from the brain via the blood
stream to body locations containing immune cells [84].
We begin our synthesis with the statement that acupunc-
ture triggers cross-talk between the neurotransmitter net-
work and the immune system that leads to NK cell
activation. This cross-talk is anchored by opiod receptors.
When the blood-borne β-endorphin arrives to lymphoid
tissues, it probably binds to opioid receptors expressed on
the surface of NK cells [85, 86]. The bound β-endorphin
stimulatesNKcellstoincreasetheexpressionofcelladhesion
molecules, cytotoxic molecules such as granzyme B and
perhaps perforin, TNF superfamily ligands [45, 49, 52, 71–
73], and the secretion of cytokines such as IFN-γ into the
cellular microenvironment [87]. These processes directly
and indirectly promote NK cell tumoricidal activities and
their ability to eliminate tumor cells and control tumor
growth. The molecular processes we are describing provide
a theoretical framework for the ﬁnding of Yamaguchi and
colleagues [39] (discussed above) that acupuncture stimula-
tion is associated with an increase in NK cell expression of
cytolytic molecules, tumoricidal activity, quantity and IFN-γ
secretion in humans.
There is insuﬃcient experimental evidence to precisely
identify the cytotoxic mechanisms through which acupunc-
ture stimulation operates to eliminate tumor cells, but we
have some clues. It has been reported that β-endorphin stim-
ulatesNKcellstoincreasetheperforin,granzymeBandIFN-
γ levels in ethanol treated Fischer rats [88]. Since acupunc-
ture stimulation also activates secretion of β-endorphin, we6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Neural circuits related to somatosympathetic reﬂexes in the gracile-thalamic-cortex pathways. Reproduced with permission from
Ma, Evid Based Complement Alternat Med 2004:1:41–47.
suspect that at least one of the pathways through which
NK cells stimulated by acupuncture treatment act to elim-
inate malignant cells is the perforin/granzyme B-mediated
secretory/necrotic mechanism of killing. In addition, IFN-γ,
induced by acupuncture stimulation, may promote expres-
sion of TNF superfamily ligands on NK cells and dendritic
cells and their non-secretory/apoptotic mechanism of killing
cancer cells mediated by these molecules [44, 49, 52, 83].
Although the scientiﬁc community will continue to sort
out the speciﬁc details of operative pathways over the
coming years, we consider there to be suﬃcient evidence to
formally hypothesize that acupuncture stimulation increases
the cytotoxic activity of NK cells (Figure 3).
Besides acting as an incubator for the activation of
NK cells, the lymphoid tissues also act as an incubator
that facilitates increases in NK cell number, which typically
varies from 2 to 18% of the total lymphocytes in human
peripheral blood [89]. As described in the previous section,
the number of mature NK cells is regulated by contin-
ual homeostatic processes that include NK cell precursor
proliferation, diﬀerentiation and mature NK cell demise.
Purine rich box-1 (PU.1) is an important regulatory gene
andtranscriptionfactorthatmasterstheentireprocessofNK
cell diﬀerentiation; it also plays a special role in controlling
proliferation during the transition from committed NK cell
precursorsto immature NK cells[66].PU.1is responsible for
the regulation of c-Jun. Importantly, acupuncture has been
found to increase the expression of c-Jun [90]. Although
no directly supporting evidence is available, the ﬁnding
that acupuncture induces increases in expression of c-Jun,
which is regulated by PU-1, suggests that acupuncture
might work through the PU.1 pathway to regulate stemEvidence-Based Complementary and Alternative Medicine 7
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of IFN-γ. This cytokine induces the expression of NK cell receptors and cytokine receptors on NK cells and perhaps cytokine secretion by
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Table 2: Studies with evidence that acupuncture stimulation modulates NK cell function in humans.
Authors, journal, year of publication Arranz et al., Am J Chin
Med, 2007
Yamaguchi et al., eCAM,
2007
Petti et al., JT r a dC h i n
Med, 1998
Subjects Women with anxiety
(controls, healthy women) Normal individuals Patients with pain
Treatment group Yes Yes Yes
Placebo control group No No No
Non-placebo control group Yes No Yes
Overall Jaded scorea 211
Scored component items of the Jaded score
Study described as randomized (Yes = 1; No = 0 ) 001
Randomization appropriate (Yes = 1; No = −1) 0 0 −1
Subject blinded (Yes = 1; No = 0 ) 000
Evaluator blinded (Yes = 1; No = 0 ) 101
Subjects that withdrew and/or dropped out
described (Yes = 1; No = 0) 110
aUsed to assess quality of methods, with 5 being the highest score possible.
cell diﬀerentiation and proliferation leading to the increased
production of mature NK cells. Proliferation of NK cells
may also be linked to IL-2, a cytokine produced by activated
T cells and dendritic cells. In the previous paragraph, we
pointed out that β-endorphin stimulates NK cells to secrete
IFN-γ into the cellular microenvironment. β-endorphin
could also simultaneously stimulate activated T cells and
dendritic cells to secrete other cytokines such as IL-2 into the
cellular microenvironment [87], which would then promote
increases in NK cell proliferation and quantity [90].
We continue our synthesis with the statement that
acupuncture-induced cross-talk is also anchored by NK-cell
receptors. Korean scientists have utilized mRNA microarray
tracking to follow gene expression patterns in NK cells
that change in response to needling ST36 in a rat model,
relative to a sham treatment group and non-treatment
group [36]. The study showed acupuncture stimulation of
ST36 produced an increase of mRNA CD94 expression,
which coded a lectin-like receptor that paired with NKG2
receptors. In turn, CD94 proteins pair with NKG2C to
form activating receptors to induce NK-cell activation via
ITAM, a tyrosine-based activation motif in NKG2C. The
authors point out that CD94 can also simultaneously form
heterodimes with NKG2A to block NK cell activity via ITIM,
a tyrosine-based inhibitory motif in NKG2A. In this model,
however, acupuncture stimulation of ST36 decreased the
expression of SHP-1, which encoded a tyrosine phosphatase
required for the inhibitory eﬀect of NKG2A. Acupuncture
stimulation of ST36 also induced expression of mRNA
PTK that encoded the PTK (including Src, Syk and Zap-
70 family). PTKs activate downstream proteins that play
important roles in multiple cellular processes including
proliferation and NK-cell activation. A more recently pub-
lished, higher quality study conﬁrms many of these ﬁndings
[91].
Another major NK cell receptor responsible for trigger-
ingNKcellcytolyticactivityisNKp44[92,93],anareainves-
tigated in several diﬀerent ways by diﬀerent research teams
in China. Importantly, the cell surface expression of NKp44
is progressively increased by NK cells during culture with IL-
2[ 93]. Experimental results demonstrate that acupuncture
of ST36 increases IL-2, both in mice [94] and in humans
[95, 96] This ﬁnding suggests that acupuncture stimulation
of ST36 also produces a sequential molecular cascade along
the following lines: needling increases secretion of IL-2,
which induces an increased expression of NKp44, thereby
leading to enhanced NK cell cytolytic activity.
6. Assessing the Evidence
To systematically assess the methodological quality of
reviewed studies, we turn to a modiﬁed version of the Jadad
scale [97, 98]. The Jaded scale is the scale most commonly
used to assess the quality of research in health studies [99].
White and Ernst modiﬁed the Jadad scale speciﬁcally to
assess acupuncture research [100–102]; their modiﬁed Jaded
scale ranges from 0 to 5 points with a higher score signifying
better methodological quality.
Results from the three human studies are statistically
signiﬁcant and consistent but the methodological quality
is low, ranging from 1 to 2 points (Table 2). One of the
primary problems is that the studies lacked either a control
group or randomization to a control group. Consequently
it is possible that changes in NK cell activity and level
may result partially or even completely from reasons other
than a direct physiological or psychological connection with
acupuncture; such alternative reasons include spontaneous
remission, the natural course of waxing and waning of
symptoms, andregressiontothemean[103].Incontrast,the
methodological quality of the cited animal studies is higherEvidence-Based Complementary and Alternative Medicine 9
Table 3: Studies with evidence that acupuncture stimulation activates NK cells.
Authors, journal, year of publication Yu et al., J Neuroimmunol,
1998 Yu et al., Jpn J Physiol, 1997 Choi et al., Neurosci Letter,
2002
Subjects
BALBrc qrq.mice, athymic
BALBrc and ICR Inbred F344 rats Sprague-Dawley rats
nurnu mice, LE rats and
New Zealand white rabbits
Treatment group Yes Yes Yes
Placebo control group Yes Yes Yes
Non-placebo control group Yes Yes Yes
Overall Jaded scorea 232
Scored component items of the Jaded score
Study described as randomized (Yes = 1; No = 0 ) 000
Randomization appropriate (Yes = 1; No = −1 ) 000
Subject blinded (Yes = 1; No = 0 ) 111
Evaluator blinded (Yes = 1; No = 0 ) 111
Subjects that withdrew and/or dropped out
Described (Yes = 1; No = 0) 010
aUsed to assess quality of methods, with 5 being the highest score possible.
Table 4: Studies with evidence that acupuncture stimulation leads to proliferation of NK cells.
Authors, journal, year of publication Kim et al., J
Neuroimmunology, 2005
Yu et al., J
Neuroimmunology, 1998
Choi et al., Neurosci Lett,
2002
Subjects Sprague-Dawley rats
BALBrc qrq.mice, athymic
BALBrc and ICR Sprague-Dawley rats
nurnu mice, LE rats and
New Zealand white rabbits
Treatment group Yes Yes Yes
Placebo control group No Yes Yes
Non-placebo control group Yes Yes Yes
Overall Jaded scorea 322
Jaded score components
Study described as randomized (Yes = 1; No = 0 ) 000
Randomization appropriate (Yes = 1; No = −1 ) 000
Subject blinded (Yes = 1; No = 0 ) 111
Evaluator blinded (Yes = 1; No = 0 ) 111
Subjects that withdrew and/or dropped out
described (Yes = 1; No = 0) 100
aUsed to assess quality of methods, with 5 being the highest score possible.
ranging from a Jaded score of 2–5. Looking speciﬁcally at the
evidence concerning the idea that acupuncture stimulation
activates NK cells (Table 3), we observe that the evidence
is consistently supportive across all three studies. All three
studies assign animals to a treatment group, placebo control
group and non-placebo control group; yet the assignment is
not random and therefore some of the critiques presented
abovehold(althoughnotasstronglyaswithhumansbecause
animals are bred to be similar). Evidence regarding the idea
that acupuncture stimulation leads to proliferation of NK
cells has a similar proﬁle (Table 4). Evidence concerning the
idea that acupuncture stimulation modulates expression of
NK cell receptors is produced from research designs that are
much stronger (Table 5).
7. FutureStudies
In drawing upon cellular immunology and molecular bio-
logical theory to develop an evidence-based hypothesis that
acupuncture enhances anticancer immunity, we provide10 Evidence-Based Complementary and Alternative Medicine
Table 5: Studies with evidence that acupuncture stimulation modulates expression of NK cell receptors.
Authors, journal, year of publication Rho et al., Mol
Cells, 2008
Kim et al., J
Neuroimmunol-
ogy,
2005
Xiao et al., Chen
Tzu Yen Chiu,
1992
Ma et al., Zhen
Ci and Yan Jiu,
1992
Wu et al.,
Chung-Kuo
Chung Hsi i
Chieh Ho Tsa
Chih, 1994
Subjects Sprague-Dawley
rats
Sprague-Dawley
rats
People with
rheumatoid
arthritis
(controls,
healthy people)
BALB/c mice
Hospital
patients
diagnosed with
a malignant
tumor prior to
surgery
Treatment group Yes Yes Yes Yes Yes
Placebo control group No No Yes No Yes
Non-placebo control group Yesb Yes Yes Yes Yes
Jaded scorea 53233
Jaded score components
Study described as randomized (yes = 1; no = 0 ) 10111
Randomization appropriate (yes = 1; no = −1) 1 0 −11−1
Subject blinded (yes = 1; no = 0 ) 11011
Evaluator blinded (yes = 1; no = 0 ) 11111
Subjects that withdrew and/or dropped out
described (yes = 1; no = 0) 11111
aUsed to assess quality of methods, with 5 being the highest score possible.
bAuthorsstate“Atthesametime,thecontrolgroupofrats(n=6)wererestrainedinholderswithoutEAstimulationorwithEAstimulationatanon-acupoint”.
a new framework for considering anew important, unre-
solved issues, some of which are speciﬁc to CAM and others
that are more interdisciplinary in nature. Within the ﬁeld of
CAM, there is considerable interest in identifying the extent
to which stimulating speciﬁc acupoints produces meaningful
results beyond the generic eﬀects that accrue from inserting
an acupuncture needle into any point on the body. Authors
of a Cochrane review, which synthesizes 40 trials involving
4858 patients, conclude that stimulating the P6 acupoint,
compared to sham, signiﬁcantly reduces nausea, vomiting,
and the need for rescue antiemetics [25]. Yet another review,
one that examines acupuncture studies across a variety
of conditions, concludes that clinical trials have failed to
demonstrate a diﬀerence in eﬀects between sham and true
acupuncture [104]. This review provides a new venue to
consider this issue of point speciﬁc eﬀects, a venue with an
outcome that can be objectively and quantitatively assessed.
An advocate of generic eﬀects would seemingly expect that
administering acupuncture to any single site on the body
would increase NK cell cytotoxicity and number. Or at best
that needling any one of a number of diﬀerent acupuncture
points would improve NK cell function and quantity in
equivalent ways. For example, one of the anonymous
reviewers suggested that a point with a segmental relation
to the lungs could be very important because the lungs
contain signiﬁcant amounts of NK cells and lymphoid
tissues. We read the literature to imply (without conclusively
demonstrating) that needling ST36 (compared to both sham
and true points) would increase the number and cytotoxicity
of NK cells in humans. In many of the animal studies,
needling ST36 alone does produce such an eﬀect [35, 36, 92].
That said, we also consider it likely that needling ST36
in conjunction with other well-chosen points would lead
to even more eﬀective immune enhancement. Indeed, the
human studies we reviewed utilized point combinations
[38–40]. Factors that may modulate the extent to which
acupuncture improves the quantity and function of NK cells
include the nature of the clinician-patient encounter [105],
the intensity of acupuncture stimulation [106], and whether
or not the clinician achieves “de qi” (achieving a sensation of
stimulation after needle insertion [107]).
Another CAM-speciﬁc item is that acupuncture likely
has beneﬁcial impact upon various other immunological
functions including T-cells [40, 108, 109]a n dB - c e l l s[ 32].
This review is focused on NK cells, but we consider it
likely that scientists could draw upon biomedical concepts
to theorize the ways in which acupuncture stimulation
enhances T cells, B cells and other immune functions. Such
reviews would not be trivial and would likely entail entirely
new research papers.
At a much broader level, this review opens up new lines
of inquiry about acupuncture and cancer. As of yet, there
are no experimental studies directly investigating whether
acupuncturestimulationpreventscancerorproducesantitu-
mor eﬀects. Such studies could proceed along the following
lines. Mice would be randomly assigned to treatment,
placebo control and non-stimulation groups. Then, normal
or transgenic inbred mice that spontaneously develop cancer
would be treated with a carcinogen for study of cancer
prevention. Normal inbred mice would be transplantedEvidence-Based Complementary and Alternative Medicine 11
with syngeneic tumor cells to investigate if the therapy
has antitumor eﬀects. The treatment groups would receive
needle stimulation, the placebo control at another point and
the non-stimulation group would not receive any needle
stimulation. The mice would be followed for carcinogen-
induced tumor appearance or tumor transplant growth and
tumor-induced death, respectively. In addition, the mice
wouldbeexaminedforNKcellnumberandfunction.Ataset
periodoftime,thegroupresultswouldbecompared,thereby
yielding either supportive or disconﬁrming evidence.
An inter-disciplinary item of great importance is the
extent to which acupuncture could complement conven-
tional therapies to improve patient outcomes. The human
studies that we reviewed are based upon research with,
respectively, anxious women, healthy volunteers and peo-
ple suﬀering pain. It is important to speciﬁcally examine
the extent to which acupuncture stimulation comparably
enhances immune functioning in patients with the multi-
factorial disease known as cancer, especially since this pop-
ulation of patients is known to have decreased NK activity
[110]. Positive results would, in our opinion, provide strong
rationale for concerted eﬀorts to integrate acupuncture into
conventional cancer care with the aim of increasing survival
and disease-free survival of patients with cancer.
8. Conclusion
In this review, we have synthesized heterogeneous research
ﬁndings with cellular immunological and molecular bio-
logical theory to produce the “acupuncture immuno-
enhancement hypothesis”. Broadly, the hypothesis proposes
that acupuncture enhances the ability of the immune system
to more actively eliminate malignant cells by increasing the
ability of NK cells to kill cancer cells. More precisely, the
hypothesis trumpets that acupuncture stimulation increases
the cytotoxicity of NK cells by promoting cross talk between
the neurotransmitter networkand immune system thatis [1]
orchestrated by nitric oxide, β-endorphin and cytokines and
[2] anchored by opioid and NK cell receptors. We intend the
“acupuncture immuno-enhancement hypothesis” to provide
a focal point for future communication and research about
the potential of acupuncture to enhance anticancer immune
functions.
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